Smartcanula
- Company typePrivate
- Founded2004
- HeadquartersLausanne, Switzerland
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
Smartcanula firmographics
Firmographics- Name
- Smartcanula
- Legal name
- SmartCanula sárl
- Website
- https://smartcanula.com
- Company type
- Private
- Founded year
- 2004
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Ownership category
- akta.pro rank
Smartcanula industry classification
Industry- Product category
- Cardiac Surgery Medical Devices
- NAICS
- Surgical and Medical Instrument Manufacturing (339112), Medical Equipment and Supplies Manufacturing (3391)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Cardiac Surgery Devices (Cannulas, Clamps, Closure, Grafts) (HLAHAFAH)
- akta.pro secondary industry
- Vascular Access & Closure Devices (Sheaths, Guidewires, Closure Systems) (HLAHAFAK)
Keywords
Where Smartcanula is headquartered
LocationHeadquarters
- HQ city
- Lausanne
- HQ country
- Switzerland
- HQ region
- Europe
Offices2 records
Markets served
Smartcanula business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure
Revenue model
- Medical Device Sales: Smartcanula generates revenue through the sale of its proprietary minimally invasive venous cannulas for cardiac surgery and cardiopulmonary bypass procedures, distributed globally through exclusive medical device distributor partnerships.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels2 records
Smartcanula product offering
Product offeringCore offering
Smartcanula designs, manufactures, and globally distributes minimally invasive venous cannulas used by hospitals and surgical teams during cardiac surgery, cardiopulmonary bypass, and extracorporeal circulation procedures. The cannulas deliver superior blood flow through a smaller vascular access point compared to conventional cannulas, with the goal of minimizing patient trauma. The company supports adoption through the smartCONCEPTS clinical framework and a worldwide network of exclusive medical-device distribution partners.
Product overview
Smartcanula is a medical device company offering a single core product line of minimally invasive venous cannulas designed for cardiac surgery and cardiopulmonary bypass procedures. The flagship product, smartcanula, provides superior blood flow through smaller access points to minimize patient trauma. The smartCONCEPTS platform represents the company's approach to implementing this technology in heart surgery settings. The company operates through a global network of exclusive distributor partners to serve hospitals across multiple regions.
Differentiator
Problem solved
Functional benefit
Brands
- smartCONCEPTS: Product concept highlighting superior blood flow and minimized trauma in heart surgery applications using smartcanula cannulas for cardiopulmonary bypass and extracorporeal circulation.
- smartDISTRIBUTORS
Products and services
- smartcanula (minimally invasive venous cannula) A minimally invasive venous cannula designed for cardiac surgery and cardiopulmonary bypass. The device is engineered to provide superior blood flow through a smaller vascular access point than conventional cannulas, minimizing patient trauma during extracorporeal circulation procedures. It is sold to hospitals and surgical teams via exclusive medical device distribution partners.
Quantifiable outcome
- Superior blood flow with smaller access point
Companies that use Smartcanula
Customer profileSegments1 record
Ideal customer profiles1 record
Smartcanula technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
Smartcanula partnerships and signals
Strategic signalScale indicators3 records
Recent moves5 records
Expansion highlights4 records
Smartcanula competitors and assessment
Company assessmentDirect peers
- Getinge (Maquet): Getinge's Maquet brand offers a comprehensive line of cardiac surgery products including venous cannulas, arterial cannulas, and full CPB systems. It competes directly with Smartcanula for cardiac surgery center contracts.
- Artivion (formerly CryoLife): Artivion specializes in cardiac and vascular surgery products including surgical adhesives, heart valves, and cardiac surgery consumables. It is a direct competitor in cardiac surgery centers where Smartcanula's cannula is sold.
- LivaNova: LivaNova (formerly Sorin Group) is a leading provider of cardiopulmonary bypass disposables including venous and arterial cannulas, oxygenators, and tubing packs. It is the most direct head-to-head competitor in CPB consumables.
- Terumo Cardiovascular Systems: Terumo is one of the largest manufacturers of cardiopulmonary bypass systems and venous cannulas globally, directly competing with Smartcanula in the cardiac surgery cannulation market. Its broader portfolio also creates bundled competition.
- Nipro Medical: Nipro manufactures a range of cardiovascular and surgical products including cannulas and perfusion disposables. It is a direct competitor in the global CPB consumables market.
Broad incumbents
- Abbott (Cardiovascular): Abbott's cardiovascular division offers cardiac surgery, structural heart, and circulatory support products. As a broad incumbent with deep hospital relationships, it represents competitive and consolidation relevance to Smartcanula.
- Fresenius Medical Care (Xenios / Fresenius Kabi): Fresenius Kabi and its Xenios business offer ECMO and ECLS cannulas that overlap with Smartcanula's extracorporeal circulation focus. It is a broader incumbent in adjacent extracorporeal therapy categories.
- Medtronic: Medtronic is a global cardiovascular medtech incumbent with broad cardiac surgery and perfusion offerings. While not a specialist in niche cannulas, its scale, R&D, and hospital relationships make it a competitive threat and a potential strategic acquirer.
- Edwards Lifesciences: Edwards is a leading cardiovascular device company with significant presence in cardiac surgery and structural heart. It represents a broad incumbent competitor and a likely strategic acquirer for niche cardiac surgery assets.
Emerging players
- Inspira Technologies: Inspira Technologies is an emerging player developing next-generation extracorporeal life support and respiratory/circulatory technologies. It represents an emerging competitive threat in the broader extracorporeal circulation space where Smartcanula operates.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks6 records
Key highlights6 records
Customer concentration
Smartcanula social profiles
Digital presenceSmartcanula financial estimates
Financial estimateRevenue estimate
Valuation estimate
Smartcanula leadership team
Management profileNumber of profiles
Profiles1 record
Smartcanula funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Smartcanula M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Smartcanula
What does Smartcanula do?
Smartcanula designs, manufactures, and globally distributes minimally invasive venous cannulas used by hospitals and surgical teams during cardiac surgery, cardiopulmonary bypass, and extracorporeal circulation procedures. The cannulas deliver superior blood flow through a smaller vascular access point compared to conventional cannulas, with the goal of minimizing patient trauma. The company supports adoption through the smartCONCEPTS clinical framework and a worldwide network of exclusive medical-device distribution partners.
Is Smartcanula a public or private company?
Smartcanula is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Smartcanula founded?
Smartcanula was founded in 2004. It employs 1 to 10 people.
Where is Smartcanula based?
Smartcanula is headquartered in Lausanne, Switzerland, in the Europe region.
How does Smartcanula make money?
One revenue line is on record: medical Device Sales.
Who are Smartcanula's main competitors?
Direct peers on record are Getinge (Maquet), Artivion (formerly CryoLife), LivaNova, Terumo Cardiovascular Systems and Nipro Medical. Broad incumbents are Abbott (Cardiovascular), Fresenius Medical Care (Xenios / Fresenius Kabi), Medtronic and Edwards Lifesciences. Inspira Technologies is listed as an emerging player.
Does Smartcanula have an API?
No public API is recorded for Smartcanula.
What industry is Smartcanula in?
Smartcanula's product category is Cardiac Surgery Medical Devices. Its primary akta.pro industry code is HLAHAFAH, Cardiac Surgery Devices (Cannulas, Clamps, Closure, Grafts), with a secondary code of HLAHAFAK, Vascular Access & Closure Devices (Sheaths, Guidewires, Closure Systems). Its NAICS code is 339112 and its SIC code is 3841.